Cantor Fitzgerald Reiterates Neutral Rating on Alnylam Pharmaceuticals (ALNY)
Go back to Cantor Fitzgerald Reiterates Neutral Rating on Alnylam Pharmaceuticals (ALNY)| Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) | Delayed: 267.40 +21.29 (8.65%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $246.11 | 52 Week High | $109.10 | |||
| Open | $246.48 | 52 Week Low | $31.38 | |||
| Day High | $269.94 | P/E | N/A | |||
| Day Low | $246.48 | EPS | $-1.45 | |||
| Volume | 3,286,310 | |||||
